Geftiget 250mg Tablet is a crucial medication used in the treatment of certain types of cancer. Its active ingredient, Gefitinib, is a targeted therapy that works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. This inhibition disrupts the signaling pathways that promote cancer cell growth and survival, particularly in non-small cell lung cancer (NSCLC) that has specific EGFR mutations. By blocking these signals, Geftiget helps to slow down or stop the progression of the disease.
Indications for Geftiget 250mg Tablet primarily include the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors express an EGFR exon 19 deletion or exon 21 (L858R) substitution.
The usual dosage is one 250mg tablet once daily. It is important to take this medication exactly as prescribed by your doctor. Side effects can include diarrhea, rash, acne, dry skin, nausea, vomiting, and stomatitis. Less common but serious side effects may occur, so it is vital to discuss any concerns with your healthcare provider.
Geftiget 250mg Tablet should be stored at room temperature, away from moisture and heat, and out of reach of children. Do not use if the seal is broken or the expiry date has passed.
